Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DCI Indonesia Tbk (DCII) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

DCI Indonesia TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

DCI Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp206,000 (market cap 491.05T, 700 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 319B, 56.8K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 1539.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (56.8K versus 700). Which is the better fit depends on your goals.

DCIIDGNS
Market Cap
491.05T319B
Volume
70056.8K
Lot
7568
Turnover
144.2M12.99M
Average Price
206,000228.63
Value
144.2M12.99M
Indicative Equilibrium Price
232
Indicative Equilibrium Volume
200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DCII
View details
DGNS
View details

About DCI Indonesia Tbk

PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.

Read more on DCII

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS